IVD Quality Control Market Size & Growth Forecast 2027–2036, By Segments (Type, Product, End Use, Application, Manufacturer Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
IVD Quality Control Market size stood at USD 1.44 Billion in 2026 and is predicted to grow at 4.54% CAGR from 2027 to 2036, surpassing USD 2.24 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.49 Billion.
Get more details on this report
Request Free Sample ReportIVD Quality Control Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by sophisticated laboratory infrastructure, widespread IVD adoption, stringent quality requirements, and demand for reliable diagnostic workflows.
- Expanding diagnostic capacity, healthcare infrastructure investments, automated diagnostics, and rising demand for accurate early disease detection are strengthening quality control adoption.
Segment Momentum
- Clinical laboratories accounted for 46.85% of the IVD quality control market in 2026, driven by high testing volumes and continuous demand for quality control systems that ensure accurate, compliant, and reproducible diagnostic results.
- Data management solutions are growing rapidly as laboratories digitize quality monitoring through centralized quality metrics, automated reporting, improved workflow efficiency, and stronger regulatory compliance across diagnostic operations.
Market Expansion Drivers
- Rising demand for accurate diagnostic testing driving laboratory quality control adoption
- Expansion of point-of-care diagnostics increasing need for standardized quality assurance systems
- Advancements in automated diagnostics improving calibration and quality monitoring workflows
Leading Market Participants
- Prominent players in the IVD quality control market include Roche Diagnostics International Ltd. (Switzerland), Abbott Laboratories (United States), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Sysmex Corporation (Japan), Becton, Dickinson and Company (United States), QIAGEN N.V. (Germany), Randox Laboratories Ltd. (United Kingdom)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.44 Billion
- 2027 Estimated Market Size: USD 1.49 Billion
- Projected Market Size: USD 2.24 Billion by 2036
- Growth Forecast: 4.54% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Quality Control (Type) | Control (Product) | Clinical Laboratories (End Use) | Immunoassay (Application) | Third Party Controls (Manufacturer Type)
- Emerging Opportunity Segment: Data Management Solutions (Type) | Calibration Verifiers (Product) | Academic and Research Institutes (End Use) | Molecular Diagnostics (Application) | Third Party Controls (Manufacturer Type)
Market Growth Drivers and Industry Trends
Rising demand for accurate diagnostic testing driving laboratory quality control adoption
The increasing emphasis on reliable clinical results will drive the IVD quality control market growth as healthcare laboratories strengthen quality assurance practices across routine and specialized diagnostic workflows. Accurate in vitro diagnostic testing depends on consistent verification of instrument performance, reagent reliability, and analytical precision before patient samples are processed. Quality control materials enable laboratories to identify deviations, minimize reporting errors, and maintain confidence in test outcomes while supporting standardized procedures across diverse diagnostic disciplines.
Expansion of point-of-care diagnostics increasing need for standardized quality assurance systems
As decentralized healthcare services continue expanding, the IVD quality control market benefits from the growing requirement to maintain consistent testing quality outside conventional laboratory environments. Point-of-care diagnostic devices are increasingly deployed in hospitals, clinics, emergency settings, and community healthcare facilities where rapid decision-making relies on dependable analytical performance. Standardized quality assurance systems help verify instrument accuracy, support operator consistency, and ensure comparable diagnostic results across multiple testing locations despite varying operational conditions.
Advancements in automated diagnostics improving calibration and quality monitoring workflows
Continuous innovation in laboratory automation will propel the IVD quality control market growth by enabling more efficient calibration and real-time quality monitoring throughout diagnostic processes. Automated diagnostic platforms integrate quality control procedures directly into testing workflows, reducing manual intervention while improving reproducibility and operational efficiency. Advanced monitoring capabilities also allow laboratories to detect analytical inconsistencies earlier, optimize instrument performance, and maintain continuous compliance with established quality management protocols across high-throughput testing environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for accurate diagnostic testing driving laboratory quality control adoption | 2% | High | North America, Europe | High | Near Term |
| Expansion of point-of-care diagnostics increasing need for standardized quality assurance systems | 1.7% | High | Asia Pacific, Latin America | High | Mid Term |
| Advancements in automated diagnostics improving calibration and quality monitoring workflows | 1.3% | High | Global | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the IVD quality control market in 2026, supported by sophisticated laboratory infrastructure, widespread adoption of in vitro diagnostic technologies, and strong emphasis on diagnostic accuracy and laboratory performance. Clinical laboratories, hospitals, and diagnostic centers increasingly rely on quality control procedures to ensure the reliability and consistency of test results, particularly as diagnostic testing becomes more integral to disease detection and treatment decisions. Established laboratory standards and stringent quality requirements further encourage the routine use of quality control products. In addition, technological advancements in diagnostic platforms and increasing demand for dependable laboratory workflows are reinforcing the region's established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest growth in the IVD quality control market, supported by expanding diagnostic testing capacity, improving healthcare infrastructure, and rising demand for reliable clinical laboratory services. Growing investments in hospitals, diagnostic centers, and laboratory facilities are increasing the need for quality assurance solutions across the region. Rising awareness of early disease detection is also encouraging greater use of diagnostic testing, creating additional requirements for consistent and accurate laboratory performance. Moreover, the modernization of healthcare systems and broader adoption of automated diagnostic technologies are encouraging laboratories to strengthen quality control practices, supporting continued market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Automated Quality AssuranceThe U.S. prioritizes advanced IVD quality control solutions that support automated diagnostic laboratories and high testing volumes. Clinical laboratories increasingly seek digital quality management tools that improve compliance and strengthen confidence in diagnostic accuracy.
Germany 🇩🇪
Regulatory Quality AlignmentGermany emphasizes robust IVD quality control practices that align with evolving regulatory requirements and laboratory accreditation standards. Diagnostic laboratories focus on standardized control materials that enhance consistency across routine clinical testing workflows.
Japan 🇯🇵
Laboratory Accuracy EnhancementJapan invests in IVD quality control systems that improve analytical precision across hospital and reference laboratories. Japanese diagnostic providers prioritize dependable control products that support reliable testing outcomes and efficient laboratory operations.
South Korea 🇰🇷
Digital Laboratory ValidationSouth Korea expands the adoption of IVD quality control technologies alongside increasingly automated diagnostic laboratories. Healthcare facilities in South Korea emphasize quality monitoring solutions that strengthen workflow efficiency and maintain consistent test reliability.
France 🇫🇷
Clinical Testing ConsistencyFrance supports the IVD quality control market through continued focus on laboratory standardization and dependable diagnostic performance. French laboratories increasingly implement comprehensive quality control programs to improve reproducibility across diverse clinical testing environments.
Italy 🇮🇹
Diagnostic Process ReliabilityItaly emphasizes practical IVD quality control solutions that reinforce reliable diagnostic services in hospital and independent laboratories. Italian laboratories prioritize standardized quality assessment practices that support consistent analytical performance and regulatory compliance.
Segment Leadership and Growth Trends
IVD Quality Control Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Quality Control (Largest Segment) vs Data Management Solutions (Fastest-Growing Segment)
The quality control segment dominated the IVD quality control market with a 63.46% share in 2026. Quality control solutions are fundamental to ensuring the accuracy, consistency, and reliability of in vitro diagnostic testing across clinical laboratories and healthcare institutions. Regular verification of analytical performance helps laboratories maintain compliance with regulatory standards while minimizing diagnostic errors and improving patient outcomes. Increasing demand for dependable laboratory testing continues to reinforce the importance of quality control practices.
The data management solutions segment is emerging as the fastest-growing category as diagnostic laboratories increasingly adopt digital technologies to streamline quality monitoring and laboratory operations. Advanced data management platforms enable centralized tracking of quality metrics, automated reporting, and improved workflow efficiency while supporting regulatory compliance. The ongoing digital transformation of laboratory environments is accelerating the adoption of integrated data management solutions.
Product Segment Analysis: Control (Largest Segment) vs Calibration Verifiers (Fastest-Growing Segment)
The control segment accounted for a 53.64% share of the IVD quality control market in 2026. Control materials are routinely used to verify the accuracy and consistency of diagnostic instruments, ensuring dependable laboratory performance across a wide range of testing procedures. Their essential role in detecting analytical variations and maintaining standardized testing processes has made them indispensable in clinical diagnostics.
The calibration verifiers segment is witnessing the fastest growth due to the increasing need to confirm instrument calibration accuracy and maintain consistent diagnostic performance. As laboratories adopt more sophisticated diagnostic platforms, calibration verification has become increasingly important for ensuring reliable analytical results and supporting stringent quality assurance requirements. This growing emphasis on precision diagnostics is driving wider adoption of calibration verifiers.
End Use Segment Analysis: Clinical Laboratories (Largest Segment) vs Academic and Research Institutes (Fastest-Growing Segment)
Holding the largest share of the IVD quality control market, the clinical laboratories segment accounted for 46.85% in 2026. Clinical laboratories perform large volumes of diagnostic testing every day, creating continuous demand for robust quality control systems that ensure accurate and reproducible results. Their responsibility to maintain regulatory compliance, operational efficiency, and high standards of patient care has sustained significant investment in quality control products and services.
The academic and research institutes segment is expected to record the fastest growth as research organizations expand studies involving advanced diagnostic technologies, biomarker discovery, and translational medicine. These institutions increasingly require comprehensive quality control practices to ensure the reliability and reproducibility of experimental findings. Growing research activity and innovation in diagnostic science continue to support strong demand within this end-use segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Quality Control, Data Management Solutions, Quality Assurance Services | Quality Control | Data Management Solutions |
| Product | Control, Calibrators, Calibration Verifiers, Others | Control | Calibration Verifiers |
| End Use | Hospitals, Clinical Laboratories, Academic and Research Institutes, Others | Clinical Laboratories | Academic and Research Institutes |
| Application | Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Others | Immunoassay | Molecular Diagnostics |
| Manufacturer Type | Third Party Controls, Original Equipment Manufacturer Controls | Third Party Controls | Third Party Controls |
Competitive Landscape and Market Positioning
Leading companies in the IVD quality control market:
- Roche Diagnostics International Ltd. (Switzerland)
- Abbott Laboratories (United States)
- Siemens Healthineers AG (Germany)
- Thermo Fisher Scientific, Inc. (United States)
- Danaher Corporation (United States)
- Bio-Rad Laboratories, Inc. (United States)
- Sysmex Corporation (Japan)
- Becton Dickinson and Company (United States)
- QIAGEN N.V. (Germany)
- Randox Laboratories Ltd. (United Kingdom)
Quality assurance has become a defining point of differentiation as laboratories place greater importance on consistent diagnostic accuracy across increasingly automated testing environments. Suppliers are strengthening their position by developing quality control solutions that integrate smoothly with digital laboratory workflows, simplify compliance, and support a broader range of diagnostic applications. As laboratory operations become more interconnected, competition is shifting toward workflow compatibility, data management capabilities, and long-term service support rather than the supply of control materials alone.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Roche Diagnostics International Ltd. (Switzerland) | |||||||
| Abbott Laboratories (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Danaher Corporation (United States) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Sysmex Corporation (Japan) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| QIAGEN N.V. (Germany) | |||||||
| Randox Laboratories Ltd. (United Kingdom) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
IVD Quality Control Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Testing Frequency | Continuous/Real-time Testing, Daily or Routine Testing, Periodic Testing, Event-driven Testing |
| Workflow Integration | Standalone Quality Control, Instrument-integrated Quality Control, Laboratory Information System-integrated Quality Control |
| Purchasing Model | Direct Procurement, Group Purchasing, Distributor-mediated Procurement |
IVD Quality Control Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Laboratory Accreditation Impact Assessment |
|
| Clinical Laboratory Procurement Benchmark |
|
| Point-of-Care Testing Quality Assurance Outlook |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of IVD quality control?
What is the projected value of the IVD quality control industry by 2036?
Why is quality control becoming increasingly important across modern diagnostic laboratories?
How are point-of-care diagnostics and laboratory automation influencing IVD quality control adoption?
Which end-use segment leads the IVD quality control market?
Why are data management solutions the fastest-growing type segment?
Why does North America lead the IVD quality control market?
What is driving IVD quality control growth in Asia Pacific?
Which companies dominate the IVD quality control landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization